Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.
2.

[Effects of Long-Term Treatment with Levetiracetam as an Adjunctive Therapy in Japanese Children with Uncontrolled Partial-Onset Seizures: A Multicenter, Open-Label Study].

Nakamura H, Osawa M, Yokoyama T, Yoshida K, Suzuki A.

Brain Nerve. 2015 Nov;67(11):1435-42. doi: 10.11477/mf.1416200317. Japanese.

PMID:
26560959
3.

Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.

Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM; Levetiracetam XR N01235 Study Group.

Epilepsia. 2009 Mar;50(3):406-14. doi: 10.1111/j.1528-1167.2008.01817.x.

4.

Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.

Delanty N, Jones J, Tonner F.

Epilepsia. 2012 Jan;53(1):111-9. doi: 10.1111/j.1528-1167.2011.03300.x. Epub 2011 Nov 2.

5.

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.

Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.

Epilepsia. 2009 Mar;50(3):398-405. doi: 10.1111/j.1528-1167.2008.01729.x. Epub 2008 Jul 24. Erratum in: Epilepsia. 2009 Apr;50(4):971.

6.
7.

Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.

Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z; N159 Study Group.

Neurology. 2006 Jun 13;66(11):1654-60. Epub 2006 Apr 26.

PMID:
16641323
8.

Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.

Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.

Epilepsy Res. 2005 Jan;63(1):1-9. Epub 2005 Jan 6.

PMID:
15716083
9.

Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.

Xiao Z, Li JM, Wang XF, Xiao F, Xi ZQ, Lv Y, Sun HB.

Eur Neurol. 2009;61(4):233-9. doi: 10.1159/000197109. Epub 2009 Jan 29.

PMID:
19176965
10.

Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.

Piña-Garza JE, Nordli DR Jr, Rating D, Yang H, Schiemann-Delgado J, Duncan B; Levetiracetam N01009 Study Group.

Epilepsia. 2009 May;50(5):1141-9. doi: 10.1111/j.1528-1167.2008.01981.x. Epub 2009 Feb 21.

11.

The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.

Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.

Epilepsy Res. 2007 Aug;76(1):6-14. Epub 2007 Aug 6.

PMID:
17681453
12.

Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial.

Glauser TA, Pellock JM, Bebin EM, Fountain NB, Ritter FJ, Jensen CM, Shields WD.

Epilepsia. 2002 May;43(5):518-24.

13.

Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study.

Chung S, Ceja H, Gawłowicz J, McShea C, Schiemann J, Lu S.

Epilepsy Res. 2016 Feb;120:7-12. doi: 10.1016/j.eplepsyres.2015.11.017. Epub 2015 Nov 25.

PMID:
26716580
14.

Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.

Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J; N01103 Levetiracetam Study Group.

Epilepsia. 2009 Nov;50(11):2377-89. doi: 10.1111/j.1528-1167.2009.02197.x. Epub 2009 Aug 21.

15.

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.

Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I.

Neurology. 2000 Jul 25;55(2):236-42.

PMID:
10908898
16.

The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.

Morrell MJ, Leppik I, French J, Ferrendelli J, Han J, Magnus L.

Epilepsy Res. 2003 May;54(2-3):153-61. Erratum in: Epilepsy Res. 2003 Oct;56(2-3):209-10.

PMID:
12837566
17.

A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.

Schiemann-Delgado J, Yang H, Loge Cde L, Stalvey TJ, Jones J, Legoff D, Mintz M.

J Child Neurol. 2012 Jan;27(1):80-9. doi: 10.1177/0883073811417183. Epub 2011 Aug 29.

PMID:
21876066
18.

Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.

Piña-Garza JE, Schiemann-Delgado J, Yang H, Duncan B, Hadac J, Hunter SJ.

Clin Ther. 2010 Oct;32(11):1935-50. doi: 10.1016/j.clinthera.2010.09.017.

PMID:
21095488
19.

Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients.

Heo K, Lee BI, Yi SD, Huh K, Kim JM, Lee SA, Shin DJ, Song HK, Lee SK, Kim JY, Lu S, Dubois C, Tonner F.

Seizure. 2007 Jul;16(5):402-9. Epub 2007 Mar 19.

20.

Supplemental Content

Support Center